Data Tables


Sections I - VIII
I.Summary Tables
II.Deceased and Living Donor Characteristics
III.Deceased Donor Organ Recovery and Disposition
IV.Organ Procurement Organization Tables
V.Kidney Tables
VI.Pancreas Transplant Alone (PTA) Tables
VII.Pancreas After Kidney (PA k) Tables
VIII.Kidney-Pancreas Tables
Sections IX - XV
IX.Liver Tables
X.Intestine Tables
XI.Heart Tables
XII.Lung Tables
XIII.Heart-Lung Tables
XIV.Donor and Recipient Tumor Tables
XV.Supplementary Tables
 Technical Notes and Analytic Methods
 All Data Tables (351 K)



View HTMLView PDF

Section X

10.1aWaiting List Patient Characteristics at End of Year Intestine Waiting List Active Waitlist Patients, 1997 to 2006Table 10.1a (41 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
10.1bWaiting List Patient Characteristics at End of Year Intestine Waiting List Active and Inactive Patient Comparison, 2002 to 2006Table 10.1b (36 k)
Age
Diagnosis
Gender
Race
Time on Waiting List
10.2Time to Transplant, 1997 to 2006 New Intestine Waiting List RegistrationsTable 10.2 (55 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
10.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Intestine Waiting ListTable 10.3 (45 k)
Age
Blood Type
Diagnosis
Gender
Race
10.4Transplant Recipient Characteristics, 1997 to 2006 Intestine RecipientsTable 10.4 (42 k)
Age
Blood Type
Residency
Gender
Race
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
10.5Incidence of Transplant, 1997 to 2006 Intestine Transplants per 1 Million PopulationTable 10.5 (29 k)
10.6aImmunosuppression Use for Induction, 1997 to 2006 Recipients with Intestine TransplantsTable 10.6a (29 k)
10.6bImmunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Intestine TransplantsTable 10.6b (31 k)
10.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Intestine TransplantsTable 10.6c (28 k)
10.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Intestine TransplantsTable 10.6d (29 k)
10.6eImmunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Intestine TransplantsTable 10.6e (30 k)
10.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Intestine TransplantsTable 10.6f (31 k)
10.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Intestine TransplantsTable 10.6g (31 k)
10.6hPersistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Intestine TransplantsTable 10.6h (29 k)
10.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Intestine TransplantsTable 10.6i (30 k)
10.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Intestine TransplantationTable 10.7 (68 k)
Blood Type
Residency
Gender
Race
Donor Age
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Any Organ
Diagnosis
10.8Adjusted Graft Survival, Intestine Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 10.8 (36 k)
Age
Gender
Race
Diagnosis
10.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine TransplantsTable 10.9 (22 k)
10.10Unadjusted Graft Survival, Intestine Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 10.10 (42 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
10.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine TransplantsTable 10.11 (22 k)
10.12Adjusted Patient Survival, Intestine Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 10.12 (36 k)
Age
Gender
Race
Diagnosis
10.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine TransplantsTable 10.13 (22 k)
10.14Unadjusted Patient Survival, Intestine Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 YearsTable 10.14 (42 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
10.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine TransplantsTable 10.15 (22 k)
10.16Prevalence of People Living with a Functioning Transplant at End of Year Intestine Recipients, 1997 to 2005Table 10.16 (40 k)
Blood Type
Residency
Gender
Race
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
10.17Transplants by State and Transplant Center, 1997 to 2006 IntestineTable 10.17 (40 k)